NRG1: An Emerging Tumor Agnostic Target

Download All

Gain expert insight into the emerging role of NRG1 fusions as rare oncogenic drivers in a variety of solid tumors and learn about the targeted therapies in development from expert commentaries, a text-based module, and a downloadable slideset.

person default
Ryma Benayed, PhD
Stephen Liu, MD

Downloadable Slideset

Review this slideset on applying emerging research to biomarker testing and treatment strategies for patients with NRG1 fusion–driven cancers by Stephen V. Liu, MD, and Ryma Benayed, PhD.

person default Ryma Benayed, PhD Stephen Liu, MD Released: February 2, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

In partnership with
Supported by an educational grant from
Elevation Oncology, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings